v3.24.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net loss $ (5,355,869) $ (2,802,487)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 1,725 1,045
Stock-based compensation 631,533 340,152
Shares issued for license 189,828
Shares issued for services 50,000
Loss on conversion of notes 92,959
Amortization of debt discount 20,000 214,429
Imputed interest 9,221
Changes in operating assets and liabilities:    
Prepaid expense (130,882) (15,000)
Accounts payable (440,337) 475,399
Accrued expenses (838,428) 373,273
Accrued expenses - related party 281,250
Deferred revenue (32,000) 22,000
Net cash used in operating activities (6,001,299) (910,890)
Cash flows from investing activities:    
Purchases of property and equipment (8,744)
Net cash used in investing activities (8,744)
Cash flows from financing activities:    
Proceeds from issuance of common stock (initial public offering), net of issuance costs 7,293,651
Proceeds from exercise of warrants 1,494,658
Proceeds from convertible notes payable 1,016,290
Proceeds from notes payable 100,000
Payments of notes payable (319,950)
Repayment of note payable and interest - related party (49,000)
Proceeds from short term insurance financing 697,534  
Payments of short term insurance financing (697,534)
Net cash provided by financing activities 8,568,359 967,290
Net increase in cash and cash equivalents 2,567,060 47,656
Cash and cash equivalents, beginning of period 57,670 10,014
Cash and cash equivalents, end of period 2,624,730 57,670
Supplemental cash flow information:    
Cash paid for interest 93,916 5,757
Cash paid for taxes
Supplemental non-cash activity    
Reclassification of warrant 11,097
Issuance of common stock upon conversion of notes payable 1,535,615
Conversion of convertible note payable 226,138
Cancellation of common stock $ 8

Source

HTML PDF
ZIP